Drugs / Cyclophosphamide (CTX)
last change Jul 2013 re-read 3 minutes ago

Cyclophosphamide (CTX)

Developed for
acute lymphoblastic leukemia
Investigated by
M.D. Anderson Cancer Center

Trials 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00671658 Nov 2002 → Jul 2013 acute lymphoblastic leukemia M.D. Anderson Cancer Center Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cyclophosphamide (CTX) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00671658 ↗